Cultures. The following nonpathogenic strains of Mycobacterium obtainable from the American Type Culture Collection were used: M. stercoris (77), M. avium (9077), M. tuberculosis var. bovis (BCG 8240) , M. tuberculosis var. bovis (599), M. leprae (4244), and M. tuberculosis (607). All of these strains attain full growth in 3 days at 37 C on Long's synthetic medium and thus grow more rapidly than their freshly isolated virulent counterparts.
The H37 and B, strains of M. tuberculosis were originally obtained from Saranac Lake and have been maintained in these laboratories for several years. Media. M. lacticola and M. stercoris were grown at room temperature on the medium described by Kohn and Harris (1941) in which glucose is the sole carbon source. For special tests the glucose was replaced by 0.1 per cent benzoic acid or m-hydroxybenzoic acid. ' A preliminary report has appeared in Science, 105, 435 (1947) and in the Abstracts of ROBERT J. FITZGERALD AND FREDERICK BERNHEIM
The pathogenic H37 and B1 strains were grown on veal infusion glycerol broth, whereas the other mycobacteria were grown on Long's synthetic medium at 37 C. For special tests the following modifications of the medium described by Dubos et al. (1946) The pH was adjusted to 7.0. This medium was also used with the addition of 2.0 per-cent agar.
Cultures were used when they were at the beginning or middle of the logarithmic growth phase. Even suspensions of washed bacteria were made by the method already described (Bernheim, 1941 ). An aliquot (3 to 7 mg dry weight of bacteria) in 2.0 ml of M 20 phosphate buffer pH 6.7 was placed in each Warburg vessel and the oxygen uptake measured with and without the addition of various compounds. Streptomycin HCl (Merck) was used. It was made up in saline and diluted with the phosphate buffer immediately before its addition to the suspension. All experiments were done at 37 C in air.
The first experiments showed that the oxidation of benzoic acid by most of these bacteria is markedly sensitive to streptomycin. As shown in figure 1, 1.0 ,ug in 2.0 ml causes an appreciable inhibition, and with 10.0 ,ug in 2.0 ml the inhibition is almost complete. Figure 1 also shows that 500 ,ug of streptamine SO4 or streptidine HCl (kindly supplied by Merck and Company) are without effect. Apparently the whole streptomycin molecule is necessary for the inhibition of the oxidation of benzoic acid, as it is for the inhibition of growth. Streptomycin, however, has no effect on the metabolism of the pathogenic bacteria which do not oxidize benzoic acid. Even 500 Mug have no effect on the increased uptake in the presence of benzoic and salicylic acids and have little effect on the oxidation of fatty acids and other substrates. Pathogenicity in these mycobacteria is accompanied by a change in metabolism and a greatly decreased sensitivity of oxidative reactions to streptomycin. This difference is not reflected in the effects of streptomycin on the growth of these organisms.
It was then necessary to determine whether the oxidation of benzoic acid was the reaction most sensitive to streptomycin. Various possible substrates were added to suspensions of the bacteria. No amino acid tested is oxidized with the exception of tyrosine by M. lacticola and asparagine by some of the other species. Higher and lower fatty acids are oxidized rapidly by all of them. Trehalose is the only sugar which is readily oxidized by most of the strains, the exceptions being the pathogenic H37 and M. stercoris. Trehalose is a disaccharide (a-glucosido-1-a-glucoside) containing two molecules of glucose linked through their aldehyde groups. Other glucose disaccharides, such as cellobiose and maltose as benzoic acid. In all cases the oxidation of benzoic acid is inhibited to a greater extent than that of any other compound tested. M. katicola oxidized m-and p-hydroxybenzoic acids as well as phenol and tyrosine. The oxidation of these hydroxy compounds is somewhat more sensitive to streptomycin than that of benzoic acid, but all these reactions require 50 ,ug per ml of streptomycin for inhibitions comparable to those obtained by 5.0 ,ug per ml in all the other nonpathogenic species. 52 per cent inhibition occurred with 0.25 ml, In this connection it may also be mentioned that the resting respiration is never inhibited by streptomycin.
There is always a latent period before the inhibition of the oxidation of benzoic acid takes effect. This may be due to a slow penetration of streptomycin into the cell or to the fact that the drug is not inhibiting the first step in the oxidation of benzoic acid but some intermediate step. Streptomycin was therefore added to the bacterial suspension at different intervals during the oxidation of benzoic ROBERT J. FITZGRALD AND FREDERICK BERNE acid, and the time was measured for the attient of a given percentage of inhibition. The time was the same whether the streptomycin was added before the benzoic acid or halfway through the oxidation process, and this indicates that the latent period is due to the time necessary for the drug to penetrate to its site of action. It also indicates that it is the oxidation of benzoic acid which is inhibited, but does not rule out the posibility that the oxidation of intermediates is also affected.
Attempts were made to determine the effect of benzoic acid concentrations on the inhibition by streptomycin, to see whether the two substances are competing for the enzyme surface. In order to do this effectively it is necessary to use relatively large concentrations of benzoic acid so that its concentration is not materially altered by the amount metabolized. It was not possible to use such concentrations as they tended to be inhibitory. Consequently, the percentage of inhibition was measured when 1.0 and 2.0 mg of benzoic acid were added and a constant amount of streptomycin was used. The first significant figures were taken after the latent period when 20 per cent or less of the benzoic acid had been oxidized. Under these conditions the following percentages of inhibition were obtained for 1.0 and 2.0 mg benzoic acid, respectively, and 5.0 ,ug per ml streptomycin: 38 and 25 per cent for M. avium, 25 and 12 per cent for M. BCG. As the oxiddation proceeds the percentages of inhibition increase and become the same for the two concentrations of benzoic acid. The indication is, therefore, that the substrate and inhibitor are competing for the enzyme.
None of the species completely oxidize benzoic acid to CO2 and H20. Usually the oxidation stops when a half of the theoretical amount of oxygen is taken up. The end product has not been identified.
DISCUSSION
A bacteriostatic agent may act by inhibiting anabolic reactions directly, thus limiting growth by interfering with the synthesis of cellular material, or indirectly by inhibiting oxidative reactions which provide the energy for such synthesis. It is evident that certain nonpathogenic mycobacteria can utilize benzoic acid as a source of energy and that this reaction is readily inhibited by streptomycin. Since there is, moreover, a parallelism between the ability of the drug to inhibit this oxidation and the growth of the organism, the evidence indicates that this may be an important mechanism in the bacteriostatic action of streptomycin. It is undoubtedly not the only mechanism. The growth of pathogenic mycobacteria which do not oxidize benzoic acid is equally well inhibited by the drug, and this is also true of a number of gram-negative bacteria that do not utilize this compound. It would seem, therefore, that there must be some general reaction which is inhibited in these organisms by streptomycin and that the inhibition of oxidative reactions is secondary. It is of interest, however, that a specific oxidation can be inhibited by a so-called antibiotic agent.
SUMMARY
A number of nonpathogenic mycobacteria oxidize benzoic acid. This oxidation is inhibited by very small amounts of streptomycin. The oxidation by these organisms of trehalose, mannitol, fatty acids, and certain other substances is less sensitive to streptomycin.
As the growth of the organisms becomes resistant to streptomycin, so does the oxidation of benzoic acid.
The oxidation of benzoic acid by mycobacteria grown in benzoic acid as the sole carbon source or grown in media containing benzoic acid is more resistant to the inhibiting action of streptomycin.
Streptamine and streptidine which do not inhibit growth do not inhibit the oxidation of benzoic acid.
Benzoic and salicylic acid stimulate the oxygen uptake of pathogenic mycobacteria but are not oxidized by them. This reaction is not inhibited by streptomycin.
Other properties of the action of streptomycin on the oxidation of benzoic acid are described.
